Abstract
Expression of PTENtumor suppressor gene has been known to dephosphorylate the phosphatidylinositol 3´ kinase (PI3K) products on the 3 prime inositol ring, resulting in reduced Akt activation. Loss of PTEN expression in OPM2 and Δ47 human myeloma lines led to high Akt activity toward insulin-like growth factor I (IGF-I). In contrast, mouse plasma cell tumor (PCT) lines, expressing wild type PTEN, did not respond to IGF-I for Akt activation. We demonstrated here that endogenous PTEN played a negative role in controlling Akt activity in both mouse PCT and NIH3T3 fibroblast lines by using anti-sense oligonucleotides against PTEN. To determine the role of src-homology 2-containing inositol 5´ phosphatase (SHIP) in regulating the PI3K/Akt pathway, we manipulated its expression by down-regulation and overexpression in myeloma, PCT and NIH3T3 lines and analysed Akt activation. Our results showed that SHIP, unlike PTEN, did not affect Akt activity in all systems analysed, despite its ability to dephosphorylate a PI3K product. Although SHIP2 expression resulted in suppression of interleukin-6-mediated mitogen-activated protein kinase activation, expression of SHIP and SHIP2 in a PTEN-null myeloma line did not suppress Akt activity. Biologically, expression of only PTEN, but not SHIP and SHIP2, resulted in growth inhibition and increased apoptosis in OPM2 myeloma line. Together, our results have established the role of PTEN, but not SHIP and SHIP2, in negatively regulating the PI3K/Akt cascade and in myeloma leukemogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA . 1996 EMBO J. 15: 6541–6551
Alessi DR, Deak M, Casamayor A, Caudwell FB, Morrice N, Norman DG, Gaffney P, Reese CB, MacDougall CN, Harbison D, Ashworth A, Bownes M . 1997 Curr. Biol. 7: 776–789
Aman MJ, Lamkin TD, Okada H, Kurosaki T, Ravichandran KS . 1998 J. Biol. Chem. 273: 33922–33928
Bellacosa A, Testa JR, Staal SP, Tsichlis PN . 1991 Science 254: 274–277
Bolland S, Pearse RN, Kurosaki T, Ravetch JV . 1998 Immunity 8: 509–516
Brauweiler A, Tamir I, Dal Porto J, Benschop RJ, Helgason CD, Humphries RK, Freed JH, Cambier JC . 2000 J. Exp. Med. 191: 1545–1554
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME . 1999 Cell 96: 857–868
Cantley LC, Neel BG . 1999 Proc. Natl. Acad. Sci. USA 96: 4240–4245
Casamayor A, Morrice NA, Alessi DR . 1999 Biochem. J. 342: 287–292
Chauhan D, Hideshima T, Pandey P, Treon S, Teoh G, Raje N, Rosen S, Krett N, Husson H, Avraham S, Kharbanda S, Anderson KC . 1999 Oncogene 18: 6733–6740
Clement S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Le Marchand-Brustel Y, Erneux C, Hue L, Schurmans S . 2001 Nature 409: 92–97
Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA . 1995 Nature 378: 785–789
Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G . 1996 Proc. Natl. Acad. Sci. USA 93: 1689–1693
del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G . 1997 Science 278: 687–689
Desikan KR, Dhodapkar MV, Munshi NC, Barlogie B . 1999 Curr. Opin. Hematol. 6: 216–221
Di Cristofano A, Pandolfi PP . 2000 Cell 100: 387–390
Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP . 1998 Nat. Genet. 19: 348–355
Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM . 1999 Nature 399: 601–605
Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS . 1999 Blood 93: 3044–3052
Franke TF, Yang S, Chang TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN . 1995 Cell 81: 727–736
Fruman DA, Meyers RE, Cantley LC . 1998 Annu. Rev. Biochem. 67: 481–507
Fruman DA, Snapper SB, Yballe CM, Davidson L, Yu JY, Alt FW, Cantley LC . 1999 Science 283: 393–397
Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC . 1999 Nature 399: 597–601
Furnari FB, Lin H, Huang HS, Cavenee WK . 1997 Proc. Natl. Acad. Sci. USA 94: 12479–12484
Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G, Stokoe D . 1998 Curr. Biol. 8: 1195–1198
Hallek M, Leif Bergsagel P, Anderson KC . 1998 Blood 91: 3–21
Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, Borowski A, Jirik F, Krystal G, Humphries RK . 1998 Genes Dev. 12: 1610–1620
Helgason CD, Kalberer CP, Damen JE, Chappel SM, Pineault N, Krystal G, Humphries RK . 2000 J. Exp. Med. 191: 781–794
Hyun T, Yam A, Pece S, Xie X, Zhang J, Miki T, Gutkind JS, Li W . 2000 Blood 96: 3560–3568
Jimenez C, Jones DR, Rodriguez-Viciana P, Gonzalez-Garcia A, Leonardo E, Wennstrom S, von Kobbe C, Toran JL, R-Borlado B, Calvo V, Copin SG, Albar JP, Gaspar ML, Diez E, Marcos MA, Downward J, Martinez AC, Merida I, Carrera AC . 1998 EMBO J. 17: 743–753
Klein B, Zhang XG, Lu ZY, Bataille R . 1995 Blood 85: 863–872
Klippel A, Kavanaugh WM, Pot D, Williams LT . 1997 Mol. Cell. Biol. 17: 338–344
Kyle RA . 2001 Oncologist 6: 119–124
Lamkin TD, Walk SF, Liu L, Damen JE, Krystal G, Ravichandran KS . 1997 J. Biol. Chem. 272: 10396–10401
Li DM, Sun H . 1997 Cancer Res. 57: 2124–2129
Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R . 1997 Science 275: 1943–1947
Li W, Hyun T, Heller M, Yam A, Flechner L, Pierce JH, Rudikoff S . 2000 Cancer Res. 60: 3909–3915
Li W, Jiang Y-X, Zhang J, Soon L, Flechner L, Kapoor V, Pierce JH, Wang L-H . 1998 Mol. Cell. Biol. 18: 5888–5898
Lioubin MN, Algate PA, Tsai S, Carlberg K, Aebersold A, Rohrschneider LR . 1996 Genes Dev. 10: 1084–1095
Liu L, Damen JE, Hughes MR, Babic I, Jirik FR, Krystal G . 1997 J. Biol. Chem. 272: 8983–8988
Liu Q, Oliveira-Dos-Santos AJ, Mariathasan S, Bouchard D, Jones J, Sarao R, Kozieradzki I, Ohashi PS, Penninger JM, Dumont D . 1998 J. Exp. Med. 188: 1333–1342
Liu Q, Sasaki T, Kozieradzki I, Wakeham A, Itie A, Dumont DJ, Penninger JM . 1999 Genes Dev. 13: 786–791
Maehama T, Dixon JE . 1998 J. Biol. Chem. 273: 13375–13378
McKay RA, Miraglia LJ, Cummins LL, Owens SR, Sasmor H, Dean NM . 1999 J. Biol. Chem. 274: 1715–1722
Muraille E, Pesesse X, Kuntz C, Erneux C . 1999 Biochem. J. 342: 697–705
Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK . 1998 Proc. Natl. Acad. Sci. USA 95: 13513–13518
Pesesse X, Deleu S, De Smedt F, Drayer L, Erneux C . 1997 Biochem. Biophys. Res. Commun. 239: 697–700
Pesesse X, Moreau C, Drayer AL, Woscholski R, Parker P, Erneux C . 1998 FEBS Lett. 437: 301–303
Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R . 1999 Proc. Natl. Acad. Sci. USA 96: 1563–1568
Potter M . 1997 Hematol. Oncol. Clin. North Am. 11: 323–347
Prasad N, Topping RS, Decker SJ . 2001 Mol. Cell. Biol. 21: 1416–1428
Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, Thomas G . 1998 Science 279: 707–710
Rameh LE, Cantley LC . 1999 J. Biol. Chem. 274: 8347–8350
Rena G, Guo S, Cichy SC, Unterman TG, Cohen P . 1999 J. Biol. Chem. 274: 17179–17183
Rohrschneider LR, Fuller JF, Wolf I, Liu Y, Lucas DM . 2000 Genes Dev. 14: 505–520
Shan X, Czar MJ, Bunnell SC, Liu P, Liu Y, Schwartzberg PL, Wange RL . 2000 Mol. Cell. Biol. 20: 6945–6957
Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW . 1998 Cell 95: 29–39
Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV . 1997 Nat. Genet. 15: 356–362
Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB, Painter GF, Holmes AB, McCormick F, Hawkins PT . 1997 Science 277: 567–570
Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW . 1998 Curr. Biol. 8: 1169–1178
Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y, Kadowaki T, Koyasu S . 1999 Science 283: 390–392
Tang ED, Nunez G, Barr FG, Guan KL . 1999 J. Biol. Chem. 274: 16741–16746
Taylor V, Wong M, Brandts C, Reilly L, Dean NM, Cowsert LM, Moodie S, Stokoe D . 2000 Mol. Cell. Biol. 20: 6860–6871
Toker A, Cantley LC . 1997 Nature 387: 673–676
Treon SP, Mollick JA, Urashima M, Teoh G, Chauhan D, Ogata A, Raje N, Hilgers JH, Nadler L, Belch AR, Pilarski LM, Anderson KC . 1999 Blood 93: 1287–1298
Urashima M, Teoh G, Chauhan D, Hoshi Y, Ogata A, Treon SP, Schlossman RL, Anderson KC . 1997 Blood 90: 279–289
Weng LP, Smith WM, Dahia PL, Ziebold U, Gil E, Lees JA, Eng C . 1999 Cancer Res. 59: 5808–5814
Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL . 1998 Proc. Natl. Acad. Sci. USA 95: 15587–15591
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, Y., Zhang, J., Murga, C. et al. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Oncogene 21, 5289–5300 (2002). https://doi.org/10.1038/sj.onc.1205650
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205650
Keywords
This article is cited by
-
The Role of PI3K/Akt and ERK in Neurodegenerative Disorders
Neurotoxicity Research (2019)
-
Optimal induction of myeloma cell death requires dual blockade of phosphoinositide 3-kinase and mTOR signalling and is determined by translocation subtype
Leukemia (2012)
-
Lipid phosphatases as drug discovery targets for type 2 diabetes
Nature Reviews Drug Discovery (2006)
-
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia
Leukemia (2006)
-
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival
Leukemia (2005)